On Thursday, Shares of Bank of America Corporation (NYSE:BAC), lost -1.10% to $17.03.
Bank of America Corp., the second-largest U.S. lender by assets, hired Bill Murphy for its prime brokerage capital strategy team, according to Bloomberg.
Murphy, formerly head of investment research at advisory firm Massey Quick & Co., joined Bank of America last month as a director, said Kristen Kaus, a spokeswoman for the Charlotte, North Carolina-based company. The firm also hired Jonathan Brenner, an analyst at Ehrenkranz Partners LP, and Sally Carlson of Telligent Capital Administration Ltd. for the capital strategy team, she said. Bloomberg Reports.
In other news, Bank of America Corporation declared a redemption notice will be presented to the property trustee for Barnett Capital III, which will result in the redemption of all $63,805,000 aggregate liquidation amount outstanding of the Floating Rate Capital Securities of Barnett Capital III.
The redemption date for these securities will be July 27, 2015, and the cash redemption price to be paid on the redemption date will be $1,000 per capital security plus accrued and unpaid distributions thereon to the redemption date. Bank of America has received all necessary approvals for these redemptions.
Bank of America Corporation, through its auxiliaries, provides banking and financial products and services for individual consumers, small and middle market businesses, institutional investors, large corporations, and governments worldwide.
Shares of Merck & Co. Inc. (NYSE:MRK), inclined 0.12% to $57.67, during its last trading session.
Merck & Co., known as MSD outside the United States and Canada, will hold its second-quarter 2015 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Tuesday, July 28. During the call, company executives will provide an overview of Merck’s performance for the quarter.
Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases.
Finally, Western Alliance Bancorporation (NYSE:WAL), ended its last trade with -1.87% loss, and closed at $33.05.
Western Alliance Bancorporation, accomplished its merger with Bridge Capital Holdings (Nasdaq: BBNK). Bridge Bank, National Association, the operating partner of Bridge Capital Holdings, has been merged with and into Western Alliance Bank, the principal operating partner of Western Alliance Bancorporation. Offices of Bridge Bank will continue to use the Bridge Bank name as a division of Western Alliance Bank.
The combined company has about $13 billion in assets and 48 offices, with banking divisions based in California, Arizona and Nevada, in addition to specialized banking services throughout the U.S.
Western Alliance Bancorporation operates as the bank holding company for Western Alliance Bank that provides various banking products and related services primarily in Arizona, California, and Nevada.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
